treatment guidelines

Research in Review

Meta-Analysis Reveals Optimal Combination Therapy for Multiple Myeloma

03/24/2017

JCP Editors

A triple-combination treatment strategy is the most effective therapy for patients with relapsed or refractory multiple myeloma, according to a meta-analysis published in the Journal of Clinical Oncology (published...

A...

03/24/2017

Journal of Clinical Pathways

Conference Coverage

ASCO Cancer Survivorship Summit

03/15/2017

JCP Editors

Cancer survivors are living longer than ever. Approximately 15.5 million cancer survivors are currently alive in the United States, according to a research report issued by the American Cancer Society—a number...

Cancer...

03/15/2017

Journal of Clinical Pathways

Research in Review

Utilization of Hospice Services Vary by Individual Physician, Disease Type

03/15/2017

JCP Editors

Hospice referral for patients with advanced cancer continues to vary significantly by individual physician and treatment department, according to research published in Journal of Oncology Practice (published online...

...

03/15/2017

Journal of Clinical Pathways

Research in Review

New Biomarker for Relapsed or Refractory MZL Identified

02/27/2017

JCP Editors

Patients with marginal zone lymphoma (MZL) who underwent prior therapy with an anti-CD20 antibody regimen may be treatable with a tyrosine kinase inhibitor approved for other blood cancers, according to research...

...

02/27/2017

Journal of Clinical Pathways

Research in Review

Genomic Profiling, Targeted Therapy Effectively Treats Histiocytic Disorders

02/17/2017

JCP Editors

Genomic profiling should be applied to patients with histiocytic disorders at diagnosis in order to guide targeted therapy, according to research published in the Journal of Clinical Investigation Insight (February...

...

02/17/2017

Journal of Clinical Pathways

Research in Review

Prior Antibiotics May Reduce Immunotherapy Efficacy in Patients With Cancer

02/14/2017

JCP Editors

Patients with cancer who receive antibiotics within a month before beginning their immunotherapy treatment may find the efficacy of their treatment reduced, according to a study that will be presented at the...

...

02/14/2017

Journal of Clinical Pathways

Department

Genomics of Estrogen Receptor-Positive Cancer Changes Following Metastasis

02/13/2017

JCP Editors

A genomic analysis revealed significant differences in the genomic landscape of estrogen receptor (ER)-positive metastatic breast cancers when compared with ER-positive primary tumors. These alterations frequently...

A...

02/13/2017

Journal of Clinical Pathways

Department

Symptoms of Menopause Influence Tamoxifen Adherence Rates

02/13/2017

JCP Editors

Common menopausal symptoms such as nausea and headaches can be used as predictive tools for adherence to the aromatase inhibitor tamoxifen, according to an analysis of data from the International Breast Cancer...

...

02/13/2017

Journal of Clinical Pathways

Research in Review

Radiotherapy Combined With Delayed Surgery Reduces Adverse Effects of Rectal Cancer Treatment

02/13/2017

JCP Editors

Short-course preoperative radiotherapy combined with delayed surgery reduces the adverse effects of rectal cancer surgery while maintaining its efficiency, according to a study published in The Lancet (published...

...

02/13/2017

Journal of Clinical Pathways

Research in Review

Cost-Effectiveness of Non–Guideline-Adherent Treatments Varies

02/13/2017

JCP Editors

Treatment preferences that do not adhere to clinical guidelines may still be cost-effective, according to a series of recently published case reports. Patients preferences for treatment sometimes divert from...

...

02/13/2017

Journal of Clinical Pathways